The PE Ratio as of November 2024 (TTM) for Lexaria Bioscience Corp. (LEXX) is -5.18

According to Lexaria Bioscience Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -5.18. This represents a change of -20.72% compared to the average of -6.53 of the last 4 quarters.

Lexaria Bioscience Corp. (LEXX) Historical PE Ratio (quarterly & annually)

How has LEXX PE Ratio performed in the past?

The mean historical PE Ratio of Lexaria Bioscience Corp. over the last ten years is -9.68. The current -5.18 PE Ratio has changed 5.25% with respect to the historical average. Over the past ten years (40 quarters), LEXX's PE Ratio was at its highest in in the February 2021 quarter at 14.92. The PE Ratio was at its lowest in in the February 2024 quarter at -14.29.

Lexaria Bioscience Corp. (LEXX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lexaria Bioscience Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lexaria Bioscience Corp. (LEXX) Average PE Ratio

How has LEXX PE Ratio performed in the past?

The current PE Ratio of Lexaria Bioscience Corp. (LEXX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Lexaria Bioscience Corp. (LEXX) PE Ratio vs. Peers

How is LEXX’s PE Ratio compared to its peers?

Lexaria Bioscience Corp.’s PE Ratio is less than Revelation Biosciences, Inc. (-0.09), greater than Zura Bio Limited (-10.87), less than Phio Pharmaceuticals Corp. (-0.19), less than ZyVersa Therapeutics, Inc. (-0.07), less than TransCode Therapeutics, Inc. (-0.20), less than Immix Biopharma, Inc. (-2.39), less than CNS Pharmaceuticals, Inc. (-0.00), less than eFFECTOR Therapeutics, Inc. (-0.00), less than Navidea Biopharmaceuticals, Inc. (0.01), less than Sonnet BioTherapeutics Holdings, Inc. (-2.73), less than SeaStar Medical Holding Corporation (-0.27), less than Virios Therapeutics, Inc. (-0.76), less than Biodexa Pharmaceuticals Plc (0), less than Oncorus, Inc. (-0.21), less than null (-0.04),

Build a custom stock screener for Lexaria Bioscience Corp. (LEXX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lexaria Bioscience Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lexaria Bioscience Corp. (LEXX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lexaria Bioscience Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.